Abstract
Introduction
The study of urinary urgency is challenging for a number of reasons, including our lack of understanding of the normal physiology of urinary sensation and the pathophysiology of abnormal sensation. Issues with nomenclature and lack of agreement about the nature of the experience of normal and abnormal urinary sensation add to this difficulty.
Materials and methods
Review of published literature and critique.
Results
Currently available tools for measurement of urgency include validated questionnaires that describe the severity of urgency and its impact on quality of life, modified bladder diaries, body maps of urgency, and measures of urinary sensation during filling cystometry. All these provide some information about the experience of urinary urgency, but no single measure currently captures its multidimensional nature.
Conclusions
Measurement of urgency in clinical practice and indeed the optimal treatment strategy has yet to come of age.
Similar content being viewed by others
References
Dmochowski R (2008) On syndromes, symptoms, and root cause. Eur Urol 54(2):256
Chapple CR, Wein AJ (2005) The urgency of the problem and the problem of urgency in the overactive bladder. BJU Int 95(3):274–275
Chapple CR, Artibani W, Cardozo LD et al (2005) The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int 95(3):335–340
De Wachter S, Wyndaele JJ (2008) How sudden is a compelling desire to void? An observational cystometric study on the suddenness of this sensation. BJU Int 101(8):1000–1003
Abrams P (2005) Urgency: the key to defining the overactive bladder. BJU Int 96(Suppl 1):1–3
Wyndaele JJ, De Wachter S (2008) Urgency in overactive bladder: translating experimental data into clinical practice. Drugs Today (Barc) 44(5):381–389
Starkman JS, Dmochowski RR (2008) Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn 27(1):13–21
Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology 68(2):318–323
Coyne K, Revicki D, Hunt T et al (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11(6):563–574
Matza LS, Thompson CL, Krasnow J et al (2005) Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn 24(3):215–225
European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products, Note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women. November 2001
Dmochowski R, Heit M, Sand P (2003) The effect of anticholingergic therapy on urgency severity in patients with overactive bladder: clinical assessment of a newly validated tool. Neurourol Urodyn 22(5):411–412 Abstract 33
Nixon A, Colman S, Sabounjian L et al (2005) A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 174(2):604–607
Freeman R, Hill S, Millard R et al (2003) Reduced perception of urgency in treatment of overactive bladder with extended-release tolteridine. Obstet Gyn 102:605–611
Cardozo L, Coyne KS, Versi E (2005) Validation of the urgency perception scale. BJU Int 95:591–596
Blaivas JG, Panagopoulos G, Weiss JP et al (2007) The urgency perception score: validation and test–retest. J Urol 177(1):199–202
Cardozo L, Dewilde T, Feyereisl J et al (2006) Solifenacin significantly reduces both urgency severity and bother: results from the flexible dose, placebo controlled, multinational SUNRISE study. Neurourol Urodyn 25(6):655 Abstr 281
Rackley R, Weiss JP, Rovner ES et al (2006) Night time dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 67:731–736
Committee for Proprietary Medicinal Products, Note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence. CPMP/EWP/18/01. EMEA (European Agency for the Evaluation of Medicinal Products), 2002, London
Landis JR, Kaplan S, Swift S et al (2003) Impact of urge incontinence severity on drug treatment efficacy. In: International continence society 33rd annual congress, Florence, Italy. https://www.icsoffice.org/publications/2003/PDF/118.PDF. Abstract 118
Yalcin I, Bump RC (2003) Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189(1):98–101
Coyne KS, Matza LS, Kopp Z et al (2006) The validation of the patient perception of bladder condition (ppbc): a single-item global measure for patients with overactive bladder. Eur Urol 49:1079–1086
Basra R, Artibani W, Cardozo L et al (2007) Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ). Eur Urol 52(1):230–237
Coyne KS, Zyczynski T, Margolis MK et al (2005) Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther 22(4):381–394
Reese PR, Pleil AM, Okano GJ et al (2003) Multinational study of reliability and validity of the King’s Health Questionnaire in patients with overactive bladder. Qual Life Res 12(4):427–442
Abrams P, Klevmark B (1996) Frequency volume charts: an indispensable part of lower urinary tract assessment. Scand J Urol Nephrol Suppl 179:47–53
Brown JS, McNaughton KS, Wyman JF et al (2003) Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology 61(4):802–809
Naoemova I, De Wachter S, Wuyts FL et al (2008) Reliability of the 24-h sensation-related bladder diary in women with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19(7):955–959
Naoemova I, De Wachter S, Wyndaele JJ (2008) Comparison of sensation-related voiding patterns between continent and incontinent women: A study with a 3-day sensation-related bladder diary (SR-BD). Neurourol Urodyn 27(6):511–514
Cardozo L, Prescott K, Serdarevic D et al (2003) Can medication prolong warning time? Neurourol Urodyn 22:468–469
Cardozo L, Dixon A (2005) Increased warning time with darifenacin: A new concept in the management of urinary urgency. J Urol 173:1214–1218
Miller JR, Botros SM, Aschkenazi SO et al (2006) Urgency on bladder palpation as a predictor of detrusor overactivity. Int Urogynecol J 17(Suppl 2):S67 (Abstract 016)
Wyndaele JJ (1998) The normal pattern of perception of bladder filling during cystometry studied in 38 young healthy volunteers. J Urol 160(2):479–481
De Wachter S, Wyndaele JJ (2003) Frequency–volume charts: a tool to evaluate bladder sensation. Neurourol Urodyn 22(7):638–642
Naoemova I, De Wachter S, Wuyts FL et al (2008) Do sensation-related bladder diaries differ between patients with urodynamically confirmed and non-objectivised urinary incontinence? Int Urogynecol J Pelvic Floor Dysfunct 19(2):213–216
Erdem E, Akbay E, Doruk E et al (2004) How reliable are bladder perceptions during cystometry? Neurourol Urodyn 23:306–309
De Wachter S, Van Meel TD, Wyndaele JJ (2008) Can a faked cystometry deceive patients in their perception of filling sensations? A study on the reliability of spontaneously reported cystometric filling sensations in patients with non-neurogenic lower urinary tract dysfunction. Neurourol Urodyn 27(5):395–398
Oliver S, Fowler C, Mundy A et al (2003) Measuring the sensations of urge and bladder filling during cystometry in urge incontinence and the effects of neuromodulation. Neurourol Urodyn 22(1):7–16
Dompeyre P, Fritel X, Bader G et al (2007) Bladder sensitivity testing using a visual analogue scale: comparative cystometric study on women. Neurourol Urodyn 26:350–355
Lowenstein L, FitzGerald MP, Kenton K et al (2008) Validation of a real-time urodynamic measure of urinary sensation. Am J Obstet Gynecol 198(6):661.e1–661.e4
Phull H, Hijaz A, Goldman H, Rackley R, Vasavada S, Daneshgari F et al (2008) Role of urodynamics on clinical decision-making in patients with urinary incontinence and voiding dysfunction. AUA meeting. http://www.abstracts2view.com/aua/. Abstract 1420
Seckiner I, Yesilli C, Mungan A et al (2007) Correlations between the ICIQ-SF score and urodynamic findings. Neurourol Urodyn 26:492–494
Diggs C, Meyer WA, Langenberg P, Greenberg P, Horne L, Warren JW (2007) Assessing urgency in interstitial cystitis/painful bladder syndrome. Urology 69(2):210–214
FitzGerald MP, Kenton KS, Brubaker L (2005) Localization of the urge to void in patients with painful bladder syndrome. Neurourol Urodyn 24(7):633–637
Conflict of interest statement
Roger R. Dmochowski has acted as a consultant to Astellas, Allergan, Novartis, Pfizer and Watson. Mary P. FitzGerald and Jean-Jacques Wyndaele have no conflicts to disclose within the last 12 months.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dmochowski, R.R., FitzGerald, M.P. & Wyndaele, JJ. Measuring urgency in clinical practice. World J Urol 27, 739–745 (2009). https://doi.org/10.1007/s00345-009-0467-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-009-0467-0